Sonya Kurzweil, clinical instructor in psychology at Cambridge Health Alliance, authored this piece about the potential of digital technologies to transform our children.
Massachusetts Eye and Ear Infirmary, along with Boston Children’s Hospital, is developing a contact lens that automatically dispenses medicine to the eye. Joe Ciolino, assistant professor of ophthalmology at Massachusetts Eye and Ear Infirmary, and Daniel Kohane, professor of anaesthesia at Boston Children’s Hospital, are working on the lens.
Researchers at Beth Israel Deaconess Medical Center are diving into an area of genetic material previously considered “junk” to hunt for cures for cancer. The hospital has launched a new Institute for RNA Medicine at its cancer center. Pier Paolo Pandolfi, the George C. Reisman Professor of Medicine, director of the cancer center and cofounder of the RNA institute, is quoted.
The link between emotions and productivity has become something of a popular concept in business. More companies are adopting the idea that managers need to be in tune to the emotions of their employees. Kimberlyn Leary, associate professor of psychology in the Department of Psychiatry at Cambridge Health Alliance, is quoted.
As Americans report feeling more isolated, some people turn to snuggling with strangers. Jacqueline Olds, associate clinical professor of psychiatry at Massachusetts General Hospital, is quoted.
Fitness tracking monitors promise to lead to all sorts of results: You’ll melt off fat just by monitoring your steps; eat better by tracking your food intake; get better sleep. But the fitness devices can cost as much as hundreds of dollars, and often aren’t as helpful as users hope they will be. Consumers should consider carefully whether a fitness monitor is worth the purchase, researchers advise in a Harvard Health Publications report. Anne Thorndike, assistant professor of medicine at Massachusetts General Hospital, is quoted.
A nasty fight that pits big-name scientists at Harvard University and the University of Oxford against each other on the effectiveness of a multibillion-dollar class of drugs may be headed toward a settlement by month’s end.
